PAX2 and synovial sarcoma: PAX2 is a similar protein, but it is more likely positive in malignant mesenchymal tumors including rhabdomyosarcoma and synovial sarcoma, so PAX2 must be cautiously used to differentiate between sarcomas and sarcomatoid RCCs [15].